Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Scudiero

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
The American Journal of Pathology|April 6, 2001
Expression and potential role of Fas-associated phosphatase-1 in ovarian cancerI Meinhold-Heerlein, F Stenner-Liewen, H Liewen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemiasI Tamm, S M Kornblau, H Segall, et al.
Cancer Research|June 1, 1992
Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screeningL Wu, A M Smythe, S F Stinson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1984
Hypersensitivity to DNA-damaging agents in cultured cells from patients with Usher's syndrome and Duchenne muscular dystrophyJ H Robbins, D A Scudiero, F Otsuka, et al.
Cancer Research|February 1, 1988
Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assayM C Alley, D A Scudiero, A Monks, et al.
Progress in Clinical and Biological Research|January 1, 1988
Development of human tumor cell line panels for use in disease-oriented drug screeningR H Shoemaker, A Monks, M C Alley, et al.
Science (New York, N.Y.)|October 16, 1992
Neural computing in cancer drug development: predicting mechanism of actionJ N Weinstein, K W Kohn, M R Grever, et al.
Cancer Research|October 23, 1997
Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agentsP M O'Connor, J Jackman, I Bae, et al.
Nature Genetics|March 4, 2000
A gene expression database for the molecular pharmacology of cancerU Scherf, D T Ross, M Waltham, et al.
Science (New York, N.Y.)|January 17, 1997
An information-intensive approach to the molecular pharmacology of cancerJ N Weinstein, T G Myers, P M O'Connor, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The American Journal of Pathology|April 6, 2001
Expression and potential role of Fas-associated phosphatase-1 in ovarian cancerI Meinhold-Heerlein, F Stenner-Liewen, H Liewen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemiasI Tamm, S M Kornblau, H Segall, et al.
Cancer Research|June 1, 1992
Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screeningL Wu, A M Smythe, S F Stinson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1984
Hypersensitivity to DNA-damaging agents in cultured cells from patients with Usher's syndrome and Duchenne muscular dystrophyJ H Robbins, D A Scudiero, F Otsuka, et al.
Cancer Research|February 1, 1988
Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assayM C Alley, D A Scudiero, A Monks, et al.
Progress in Clinical and Biological Research|January 1, 1988
Development of human tumor cell line panels for use in disease-oriented drug screeningR H Shoemaker, A Monks, M C Alley, et al.
Science (New York, N.Y.)|October 16, 1992
Neural computing in cancer drug development: predicting mechanism of actionJ N Weinstein, K W Kohn, M R Grever, et al.
Cancer Research|October 23, 1997
Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agentsP M O'Connor, J Jackman, I Bae, et al.
Nature Genetics|March 4, 2000
A gene expression database for the molecular pharmacology of cancerU Scherf, D T Ross, M Waltham, et al.
Science (New York, N.Y.)|January 17, 1997
An information-intensive approach to the molecular pharmacology of cancerJ N Weinstein, T G Myers, P M O'Connor, et al.
Pageof 4